Often, drug research has focused on tiny molecules, but peptide alliances are progressively gaining traction. This innovative methodology embraces combining short amino acid chains with complementary therapeutic methods to tackle intricate illness targets. By leveraging the specific properties of peptidic compounds – such as substantial selectivi